In Silico Pharmacology provides a forum for research articles at the cross-roads of computation, pharmacology, toxicology and pharmaceutics, and is relevant to all areas of basic science and therapeutics. Within this context, neuroscience and drug discovery are areas of special interest to the journal, as are state-of-the-art multiscale modelling, informatics, artificial intelligence, and big data.
Journal information
- Editor-in-Chief
-
- Boris Gutkin,
- Pramod Nair,
- Defang Ouyang,
- Chang-Guo Zhan
- Publishing model
- Hybrid (Transformative Journal). How to publish with us, including Open Access
Journal metrics
- 30 days
- Submission to first decision (Median)
- 34,443 (2021)
- Downloads
Latest issue
Latest articles
-
-
Identification of vaccine candidate against Omicron variant of SARS-CoV-2 using immunoinformatic approaches
Authors (first, second and last of 5)
-
Khaya grandifoliola active fraction as a source of therapeutic compounds for Alzheimer’s disease treatment: In silico validation of identified compounds
Authors (first, second and last of 4)
-
Optimizing the Sunitinib for cardio-toxicity and thyro-toxicity by scaffold hopping approach
Authors (first, second and last of 5)
-
Investigation of the mechanism of Shen Qi Wan prescription in the treatment of T2DM via network pharmacology and molecular docking
Authors (first, second and last of 7)
About this journal
- Electronic ISSN
- 2193-9616
- Abstracted and indexed in
-
- BIOSIS
- Baidu
- CLOCKSS
- CNKI
- CNPIEC
- Dimensions
- EBSCO Academic Search
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Meta
- Naver
- OCLC WorldCat Discovery Service
- Portico
- ProQuest Advanced Technologies & Aerospace Database
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- PubMedCentral
- Reaxys
- TD Net Discovery Service
- Wanfang
- Copyright information
